Vir Biotechnology, Inc.

Vir Biotechnology, Inc.

Vir Biotechnology, Inc.

Overview
Date Founded

2016

Headquarters

499 Illinois Street,Suite 500,5th floor,San Francisco, CA 94158

Type of Company

Public

Employees (Worldwide)

327

Industries

Biotechnology
Medical Support Services
Hospitals & Patient Services

Company Description

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Contact Data
Trying to get in touch with decision makers at Vir Biotechnology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Chairman & Co-Founder

President & Chief Executive Officer

Chief Financial Officer, Secretary & Principal Accounting Officer

Senior Vice President & General Counsel

Chief Technology Officer

Chief Information Officer

Executive Vice President, Research & Chief Scientific Officer

Chief Business Officer

Chief Human Resources Officer

Board of Directors

Venture Partner at ARCH Venture Partners

Co-Founder at Alnylam Pharmaceuticals, Inc.

Senior Managing Partner at Softbank Investment Advisers (US), Inc.

Co-Chair, Scientific Advisory Board at Amgen, Inc.

Founder at Life Sciences Advisory LLC

President & Chief Executive Officer at Vir Biotechnology, Inc.

Former Governor of Arizona

Managing Director at Alta Partners Management Corp.

Executive Chairman at Akili Interactive Labs, Inc.

Chief Executive Officer at Vividion Therapeutics, Inc.

Paths to Vir Biotechnology, Inc.
Potential Connections via
Relationship Science
You
Vir Biotechnology, Inc.
Owners & Shareholders
Details Hidden

SoftBank Investment Advisers is a global advisory firm that seeks to make investments in the technology sector. They focus on growing businesses run by disruptive innovators that are seeking to be the foundational platforms of the information revolution.

Details Hidden

Temasek-IM is an active, long-term manager which takes stakes in regional or global companies with significant potential. The firm aims to build companies into profitable operations while promoting sound corporate governance. They do not involve themselves in commercial or operational decisions except to exercise shareholder voting rights and help companies recruit management. Their investment decisions are taken independently of the Singapore Government. Temasek-IM has a long term investment horizon and because they invest off their own balance sheet, they are not constrained by ‘fund life’. As an owner investor, the firm is mostly invested in equities but do not set limits for geographies, sectors, or asset classes. Their global portfolio spans a broad spectrum of industries: financial services; telecommunications, media & technology; consumer & real estate; transportation & industrials; life sciences & agribusiness; as well as energy & resources. Temasek-IM invests in companies based in Singapore, Asia and the OECD countries.

Details Hidden

The Foundation Trust holds the endowment, including the annual installments of Warren Buffett’s gift, and funds the foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment continues to be managed, as it has been for more than 10 years, by a team of outside investment managers. The trust invests undistributed assets, with the exclusive goal of maximizing the return on investment. Investments include companies that have been criticized for worsening poverty in the same developing countries where the foundation is attempting to relieve poverty. The majority of the trust's assets are invested in government and corporate bonds, with additional holdings in commercial paper and other short-term debt securities. The trust engages in substantial foreign currency transactions, options and futures trading and lending out of securities.

Recent Transactions
Details Hidden

Vir Biotechnology, Inc. issued USD Common Stock

Details Hidden

Vir Biotechnology, Inc. raised money in a private placement transaction

Details Hidden

Vir Biotechnology, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onVir Biotechnology, Inc. issued USD Common Stock

Underwriter

Advised onVir Biotechnology, Inc. issued USD Common Stock

Escrow Agent

Advised onVir Biotechnology, Inc. issued USD Common Stock

Associate

Advised onVir Biotechnology, Inc. issued USD Common Stock

Legal Advisor

Advised onVir Biotechnology, Inc. issued USD Common Stock

Legal Advisor

Advised onVir Biotechnology, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, Palo Alto at Cooley LLP

Advisor

Venture Partner at ARCH Venture Partners

Clients

The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington.

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Key Stats and Financials As of 2020
Market Capitalization
$6B
Total Enterprise Value
$2.52B
Earnings Per Share
$-2.51
Revenue
$76.4M
EBITDAMargin
-376.25%
EBITDA
$-287M
Net Profit
$-299M
Total Debt
$71.1M
Total Equity
$717M
Enterprise Value / Sales
32.96x
TEVNet Income
-8.43x
Debt TEV
0.03x
Three Year Compounded Annual Growth Rate Of Revenue
204.38%
Non-Profit Donations & Grants Received
Investors
Details Hidden

SoftBank Investment Advisers is a global advisory firm that seeks to make investments in the technology sector. They focus on growing businesses run by disruptive innovators that are seeking to be the foundational platforms of the information revolution.

Details Hidden

Temasek Capital invests in both public and private companies across the Globe. The firm targets companies in the fields of financial services, telecommunications, media & technology, transportation & industrials, life sciences & agriculture, consumer & real estate, energy & resources and others. They provides financing for early to mid-stage capital requirement.

Details Hidden
Suppliers
Alnylam Pharmaceuticals, Inc. Medical Support Services | Cambridge, Massachusetts

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Xencor, Inc. Biotechnology | Monrovia, CA

Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

AstraZeneca Plc Other Manufacturing | Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vir Biotechnology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vir Biotechnology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vir Biotechnology, Inc..